ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
Company profile
Ticker
AMPE
Exchange
Website
CEO
Michael Macaluso
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Chay Enterprises, Inc.
SEC CIK
Corporate docs
IRS number
260179592
AMPE stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
15 Apr 24
25
Voluntary exchange delisting
4 Apr 24
10-K
2023 FY
Annual report
27 Mar 24
8-K
Ampio Announces Voluntary Delisting and SEC Deregistration
25 Mar 24
EFFECT
Notice of effectiveness
5 Mar 24
8-K
Termination of a Material Definitive Agreement
28 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Feb 24
POS AM
Prospectus update (post-effective amendment)
28 Feb 24
RW
Registration withdrawal request
28 Feb 24
Transcripts
AMPE
Earnings call transcript
2021 Q4
29 Mar 22
AMPE
Earnings call transcript
2021 Q3
11 Nov 21
AMPE
Earnings call transcript
2021 Q2
4 Aug 21
AMPE
Earnings call transcript
2021 Q1
7 May 21
AMPE
Earnings call transcript
2021 Q1
5 May 21
AMPE
Earnings call transcript
2020 Q4
4 Mar 21
AMPE
Earnings call transcript
2020 Q3
6 Nov 20
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.40 mm | 6.40 mm | 6.40 mm | 6.40 mm | 6.40 mm | 6.40 mm |
Cash burn (monthly) | 185.00 k | 879.08 k | 466.67 k | 838.33 k | 185.00 k | 879.08 k |
Cash used (since last report) | 1.27 mm | 6.06 mm | 3.22 mm | 5.78 mm | 1.27 mm | 6.06 mm |
Cash remaining | 5.12 mm | 341.29 k | 3.18 mm | 622.05 k | 5.12 mm | 341.29 k |
Runway (months of cash) | 27.7 | 0.4 | 6.8 | 0.7 | 27.7 | 0.4 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 27 |
Opened positions | 3 |
Closed positions | 15 |
Increased positions | 2 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 10.59 mm |
Total shares | 6.06 mm |
Total puts | 0.00 |
Total calls | 289.60 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 5.60 mm | $2.21 mm |
Terker Bruce E | 454.22 k | $0.00 |
Cypress Capital Management | 469.00 | $1.71 mm |
Advisor | 414.00 | $1.51 mm |
GHP Investment Advisors | 300.00 | $987.00 k |
MS Morgan Stanley | 267.00 | $972.00 k |
Sunbelt Securities | 216.00 | $786.00 k |
Tower Research Capital | 114.00 | $415.00 k |
UBS UBS Group AG - Registered Shares | 104.00 | $379.00 k |
JPM JPMorgan Chase & Co. | 101.00 | $368.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jun 23 | Buchi J Kevin | Common Stock | Buy | Acquire P | No | No | 0.2875 | 21,858 | 6.28 k | 146,858 |
8 Jun 23 | Buchi J Kevin | Common Stock | Buy | Acquire P | No | No | 0.296 | 25,000 | 7.40 k | 125,000 |
24 May 23 | Michael A Martino | Common Stock | Buy | Acquire P | No | No | 0.2877 | 76,890 | 22.12 k | 76,890 |
16 May 23 | Buchi J Kevin | Common Stock | Buy | Acquire P | No | No | 0.2743 | 32,534 | 8.92 k | 100,000 |
15 May 23 | Buchi J Kevin | Common Stock | Buy | Acquire P | No | No | 0.2466 | 44,026 | 10.86 k | 67,466 |
12 May 23 | Buchi J Kevin | Common Stock | Buy | Acquire P | No | No | 0.2352 | 23,440 | 5.51 k | 23,440 |
News
Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY
27 Mar 24
Ampio Reports Voluntary Delisting And SEC Deregistration
25 Mar 24
12 Health Care Stocks Moving In Thursday's Intraday Session
29 Feb 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
28 Feb 24
Ampio Pharmaceuticals Files FormRW To Terminate That Certain At The Marketing Offering Agreement, Dated September 18, 2023
28 Feb 24